Modern pharmaceutical research generates enormous volumes of biological and experimental data across multiple systems. However, much of this data remains fragmented across laboratory systems, research tools, and bioinformatics pipelines, limiting its usefulness for analytics and predictive discovery. A Life Sciences organization working on early-stage drug discovery and pre-clinical research approached VirtueCloud to build a scalable data platform that could unify and operationalize their research data. Their scientific and bioinformatics teams were dealing with highly complex multimodal datasets, including experimental outputs, clinical annotations, and next-generation sequencing (NGS) pipeline data. Key Challenges: - Siloed biological datasets across multiple research tools - Significant manual effort required to prepare datasets for analysis - Limited ability to correlate genomic signals with experimental outcomes - Lack of a unified AI/ML-ready data foundation - Need to operate within a regulated Life Sciences environment while enabling rapid scientific experimentation Scale & Complexity: - High-volume genomic and sequencing data - Compute-intensive analytics workloads - Collaboration between scientists, bioinformaticians, and data science teams - Compliance requirements for secure scientific data management The organization needed a Minimum Viable Platform (MVP) that could unify research datasets, accelerate scientific workflows, and provide a foundation for advanced analytics and AI-driven discovery.